Trademark: 79186760
Word
IRZION
Status
Dead
Status Code
404
Status Date
Monday, April 22, 2019
Serial Number
79186760
Registration Number
5097986
Registration Date
Tuesday, December 13, 2016
Mark Type
4000
Filing Date
Saturday, March 12, 2016
Published for Opposition
Tuesday, September 27, 2016
Cancellation Date
Monday, April 22, 2019

Trademark Owner History
Novartis AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Nov 15, 2019
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Nov 15, 2019
Death Of International Registration
Oct 27, 2017
Notification Processed By Ib
Jul 8, 2017
Final Decision Transaction Processed By Ib
Mar 15, 2017
Final Disposition Notice Sent To Ib
Mar 15, 2017
Final Disposition Processed
Mar 13, 2017
Final Disposition Notice Created, To Be Sent To Ib
Dec 13, 2016
Registered-Principal Register
Sep 27, 2016
Official Gazette Publication Confirmation E-Mailed
Sep 27, 2016
Published For Opposition
Sep 7, 2016
Notification Of Possible Opposition Sent To Ib
Sep 7, 2016
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 7, 2016
Notification Of Notice Of Publication E-Mailed
Aug 19, 2016
Law Office Publication Review Completed
Aug 17, 2016
Approved For Pub - Principal Register
Jul 25, 2016
Teas/Email Correspondence Entered
Jul 25, 2016
Correspondence Received In Law Office
Jul 15, 2016
Refusal Processed By Ib
Jul 14, 2016
Assigned To Lie
Jul 8, 2016
Teas Response To Office Action Received
Jun 30, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 30, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 27, 2016
Non-Final Action Mailed - Refusal Sent To Ib
May 27, 2016
Refusal Processed By Mpu
May 27, 2016
Non-Final Action (Ib Refusal) Prepared For Review
May 26, 2016
Non-Final Action Written
May 21, 2016
Application Filing Receipt Mailed
May 20, 2016
Assigned To Examiner
May 17, 2016
New Application Office Supplied Data Entered In Tram
May 13, 2016
Limitation From Original Application Entered
May 12, 2016
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24